<p>Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Naprelan FDA Label" href="#reference-L6582">12</a></sup><sup class="text-reference-group"><a class="reference-popover-link" data-content="Naprosyn FDA Label" href="#reference-L6583">13</a></sup><sup class="text-reference-group"><a class="reference-popover-link" data-content="Brutzkus JC, Varacallo M: Naproxen . (PubMed ID 30247840)" href="#reference-A178975">3</a></sup> Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Brutzkus JC, Varacallo M: Naproxen . (PubMed ID 30247840)" href="#reference-A178975">3</a></sup></p>